The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 27 Feb 2007
doi: 10.1242/jcs.003335
Research Article
Metalloproteinase axes increase
-catenin signaling in primary mouse mammary epithelial cells lacking TIMP3
Carlo V. Hojilla,
Ira Kim,
Zamaneh Kassiri,
Jimmie E. Fata,
Hui Fang,
and
Rama Khokha*
* Author for correspondence (e-mail: rkhokha{at}uhnres.utoronto.ca)
Multiple cancers exhibit mutations in
-catenin that lead to increased stability, altered localization or amplified activity.
-catenin is situated at the junction between the cadherin-mediated cell adhesion and Wnt signaling pathways, and TIMP3 functions to alter
-catenin signaling. Here we demonstrate that primary mouse embryonic fibroblasts (MEFs) and mammary epithelial cells (MECs) deficient in Timp3 have increased
-catenin signaling. Functionally, the loss of TIMP3 exerted cell-type-specific effects, with Timp3-/- MEFs being more sensitive and Timp3-/- MECs more resistant to EGTA-induced cell detachment than the wild type. Timp3-/- MECs had higher dephosphorylated
-catenin levels and increased
-catenin transcriptional activity as measured by TCF/LEF-responsive reporter assays. Real-time PCR analysis of
-catenin target genes in MEFs and MECs showed no alteration in Myc, decreased Ccnd1 (cyclin D1) and increased Mmp7 mRNA levels upon loss of TIMP3, with the latter occurring only in epithelial cells. Recombinant TIMP3 and synthetic metalloproteinase inhibitors reverted the increase in dephosphorylated
-catenin, decrease in Ccnd1 gene expression and increase in Mmp7 gene expression. Physiologically, Timp3-/- mammary glands displayed accelerated mammary ductal elongation during pubertal morphogenesis. Gain-of-function studies using slow-release TIMP-containing pellets revealed distinct effects of individual TIMPs on ductal morphogenesis. Recombinant TIMP1, TIMP3 and TIMP4 inhibited ductal elongation whereas TIMP2 promoted this process.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Francis, J. Bergsied, C. E. Isaac, C. H. Coschi, A. L. Martens, C. V. Hojilla, S. Chakrabarti, G. E. DiMattia, R. Khoka, J. Y. J. Wang, et al.
A Functional Connection between pRB and Transforming Growth Factor {beta} in Growth Inhibition and Mammary Gland Development
Mol. Cell. Biol.,
August 15, 2009;
29(16):
4455 - 4466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saleem, I. Murtaza, R. S. Tarapore, Y. Suh, V. M. Adhami, J. J. Johnson, I. A. Siddiqui, N. Khan, M. Asim, B. B. Hafeez, et al.
Lupeol inhibits proliferation of human prostate cancer cells by targeting {beta}-catenin signaling
Carcinogenesis,
May 1, 2009;
30(5):
808 - 817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Anglesio, J. M. Arnold, J. George, A. V. Tinker, R. Tothill, N. Waddell, L. Simms, B. Locandro, S. Fereday, N. Traficante, et al.
Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors
Mol. Cancer Res.,
November 1, 2008;
6(11):
1678 - 1690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ali and V. Knauper
Phorbol Ester-induced Shedding of the Prostate Cancer Marker Transmembrane Protein with Epidermal Growth Factor and Two Follistatin Motifs 2 Is Mediated by the Disintegrin and Metalloproteinase-17
J. Biol. Chem.,
December 28, 2007;
282(52):
37378 - 37388.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2007